Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).

A new analysis explored if age, numerous comorbidities, the use of CVD medication and Charleston Comorbidity Index scores can be used to predict mortality among confirmed COVID-19 patients. 

Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.

The teams behind the ACC's National Cardiovascular Data Registry and SVS Vascular Quality Initiative will collaborate on the project.

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.

After a brutal two months of significant revenue losses, hospitals saw a slight improvement in margins during May, according to the latest Flash Report from Kaufman Hall.